Rocuronium Bromide Injection
Product Images NDC 0143-9251
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Rocuronium Bromide (NDC 0143-9251). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Rocuronium Bromide Injection 10
Figure 1: Time To 80% Or Greater Block Vs. Initial Dose Of Rocuronium Bromide By Age Group (median, 25th And 75th Percentile, And Individual Values) (Rocuronium Bromide Injection 2)
Figure 2: Duration Of Clinical Effect Vs. Initial Dose Of Rocuronium Bromide By Age Group (median, 25th And 75th Percentile, And Individual Values) (Rocuronium Bromide Injection 3)
Figure 3: Duration Of Clinical Effect Vs. Number Of Rocuronium Bromide Maintenance Doses, By Dose (Rocuronium Bromide Injection 4)
Plb035-wes.2 (Rocuronium Bromide Injection 5)
Plb036/wes.2 (Rocuronium Bromide Injection 6)
Rocuronium Bromide Injection 7
Rocuronium Bromide Injection 8
Rocuronium Bromide Injection 9
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.